Attest Laboratories
is interested in partnering up on the following tender opportunity:
Tender notice title: Connected Care Medical Module
Publication date 2022/09/20
Closing date and time 2022/11/09 14:00 EST
Attest Laboratories details
Non-invasive metabolite biomarker test device by MRS
Attest is developing the next generation of biomarker test technology for diabetes and other metabolic conditions. Our magnetic resonance system can test metabolite biomarkers like glucose and lactate with a simple finger scan and without breaking the skin. Our solution obviates recurring costs of disposable reagent test strips and sensors and mitigates workflow challenges of metabolite specific test devices.
First name David
Last name O'Brien
President
Support
Contact us directly, or find your answers using resource guides.
